Mergers & Acquisitions ·
Sanara MedTech Inc. reported second quarter 2026 financial results with net revenue increasing 9% to $28.1 million…
SMTISanara MedTech Inc.
Sanara MedTech Inc. reported second quarter 2026 financial results with net revenue increasing 9% to $28.1 million from $25.8 million in the prior year period. Gross profit rose to $26.2 million, or 93% of net revenue, while operating income decreased to $1.8 million from $2.5 million. The company reported a net loss from continuing operations of $0.4 million, or $0.05 per diluted share, compared to net income of $0.5 million in the same quarter last year. Adjusted EBITDA increased 7% to $5.0 million. For the first six months of 2026, net revenue grew 14% to $55.9 million and adjusted EBITDA reached $9.3 million. The company holds $15.4 million in cash and $46.5 million in long-term debt as of June 30, 2026. Management announced a transformational agreement to be acquired by MIMEDX Group Inc., pending customary closing conditions. Sanara MedTech is a medical technology company focused on developing and commercializing surgical products for the tissue repair market.